- Home
- TCRX vs USIO Comparison
TCRX vs USIO Comparison
Compare TCRX & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCRX | USIO |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 58.8M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TCRX | USIO |
|---|---|---|
| Price | $0.75 | $2.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $7.00 | $4.00 |
| AVG Volume (30 Days) | ★ 470.4K | 335.2K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $10,325,000.00 | ★ $28,200,535.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | $19.81 | $8.57 |
| P/E Ratio | ★ N/A | $254.00 |
| Revenue Growth | ★ 266.65 | 12.69 |
| 52 Week Low | $0.72 | $1.03 |
| 52 Week High | $2.57 | $2.98 |
Technical Indicators
Market Signals| Indicator | TCRX | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.29 | 73.17 |
| Support Level | $0.72 | $1.36 |
| Resistance Level | $0.80 | N/A |
| Average True Range (ATR) | 0.04 | 0.20 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 50.00 | 80.27 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.